313 related articles for article (PubMed ID: 31207934)
1. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.
Bernelin-Cottet C; Urien C; Stubsrud E; Jakob V; Bouguyon E; Bordet E; Barc C; Boulesteix O; Contreras V; Barnier-Quer C; Collin N; Trus I; Nauwynck H; Bertho N; Schwartz-Cornil I
Viruses; 2019 Jun; 11(6):. PubMed ID: 31207934
[TBL] [Abstract][Full Text] [Related]
2. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.
Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I
Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
4. Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection.
Sirisereewan C; Nedumpun T; Kesdangsakonwut S; Woonwong Y; Kedkovid R; Arunorat J; Thanawongnuwech R; Suradhat S
Vet Immunol Immunopathol; 2017 Jan; 183():7-15. PubMed ID: 28063479
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
Suradhat S; Wongyanin P; Sirisereewan C; Nedumpun T; Lumyai M; Triyarach S; Chaturavittawong D; Paphavasit T; Panyatong R; Thanawongnuwech R
Vaccine; 2016 Jan; 34(5):609-615. PubMed ID: 26724543
[TBL] [Abstract][Full Text] [Related]
6. Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction.
Renukaradhya GJ; Meng XJ; Calvert JG; Roof M; Lager KM
Vaccine; 2015 Aug; 33(33):4069-80. PubMed ID: 26148878
[TBL] [Abstract][Full Text] [Related]
7. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
9. Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus.
Du L; Li B; Pang F; Yu Z; Xu X; Fan B; Tan Y; He K; Huang K
Vet Immunol Immunopathol; 2017 Jan; 183():31-39. PubMed ID: 28063474
[TBL] [Abstract][Full Text] [Related]
10. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
[TBL] [Abstract][Full Text] [Related]
11. Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
Pujhari S; Baig TT; Hansra S; Zakhartchouk AN
Virus Res; 2013 May; 173(2):321-6. PubMed ID: 23353778
[TBL] [Abstract][Full Text] [Related]
12. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
[TBL] [Abstract][Full Text] [Related]
14. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.
Bassaganya-Riera J; Thacker BJ; Yu S; Strait E; Wannemuehler MJ; Thacker EL
Viral Immunol; 2004; 17(1):25-37. PubMed ID: 15018660
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
17. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
[TBL] [Abstract][Full Text] [Related]
18. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
19. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
